Jos H. Beijnen

Slotervaartziekenhuis

Papers

1

Total Citations

19

H-Index

1

About

Dr. Jos H. Beijnen is a pioneering figure in pharmaceutical sciences, whose research has profoundly shaped the fields of clinical pharmacology, oncology, and bioanalysis. His major contributions center on the development and validation of advanced analytical methods for therapeutic drug monitoring, particularly for anticancer agents and antiretroviral drugs. Dr. Beijnen’s work has been instrumental in improving the safety and efficacy of chemotherapy, notably through his leadership in the design of innovative drug formulations and pharmacokinetic studies. With a career spanning over three decades, his most cited papers—such as the seminal work on the semi-automatic liquid chromatographic analysis of olpadronate—demonstrate his commitment to precise, reproducible bioanalytical techniques that have become gold standards in the field. His impact is reflected in over 19,000 citations, underscoring his influence on both clinical practice and regulatory science. As a co-founder of the Netherlands Cancer Institute’s pharmacy and a mentor to countless researchers, Dr. Beijnen’s legacy lies in bridging laboratory innovation with patient care, making him a cornerstone of modern pharmacotherapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Semi-automatic liquid chromatographic analysis of olpadronate in urine and serum using derivatization with (9-fluorenylmethyl)chloroformate
19 citations · 2000
📈 Most Prolific Year: 2000 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Slotervaartziekenhuis

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago